Foghorn Therapeutics Inc. Business Finance Contracts & Agreements
11 Contracts & Agreements
- Investor Rights Agreements (3 contracts)
- Loan Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (1)
- Warrant Agreements (2)
- Stock Purchase Agreement, dated as of December 10, 2021, between Foghorn Therapeutics Inc. and Eli Lilly and Company (Filed With SEC on December 13, 2021)
- Amendment to Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 10, 2021 (Filed With SEC on December 13, 2021)
- First Amendment to Loan and Security Agreement dated as of June 14, 2021, among Oxford Finance LLC and Foghorn Therapeutics Inc (Filed With SEC on June 15, 2021)
- Loan and Security Agreement dated as of November 19, 2020, among Oxford Finance LLC, and Foghorn Therapeutics Inc (Filed With SEC on November 25, 2020)
- Form of Warrant to Purchase Common Stock of Foghorn Therapeutics Inc., dated as of November 19, 2020 (Filed With SEC on November 25, 2020)
- Foghorn Therapeutics Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on October 19, 2020)
- Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 18, 2018 (Filed With SEC on October 19, 2020)
- Specimen stock certificate evidencing shares of common stock (Filed With SEC on October 19, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 19, 2020)
- Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 18, 2018 (Filed With SEC on October 2, 2020)
- Form of Warrant to Purchase Series A-2 Preferred Stock of the Registrant issued to Silicon Valley Bank, dated November 29, 2016 (Filed With SEC on October 2, 2020)
